Recombinant hyperimmune gammaglobulin for primary immunodeficiency

Ended Project Grant Awarded Last action

Award ID
R44AI124901
Recipient
Awarding agency
Obligated
$1,499,857

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Place of performance
South San Francisco, CA 94080, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $749,659
Original award $750,198

Quick answers

Who received award R44AI124901?

R44AI124901 was awarded to Gigagen Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2016.

How much is award R44AI124901 worth?

$1,499,857 has been obligated on R44AI124901.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award